Effects of an orexin receptor 2-selective agonist on blood pressure nocturnal dipping profile in patients with narcolepsy type 1

被引：0

作者：

Karas, Marta ^{[1
]}

Onorati, Francesco ^{[1
]}

Tracey, Brian ^{[1
]}

Cai, Alice ^{[1
]}

Barateau, Lucie ^{[2
,3
,4
]}

Dauvilliers, Yves ^{[2
,3
,4
]}

Volfson, Dmitri ^{[1
]}

机构：

[1] Takeda Dev Ctr Amer Inc, Cambridge, MA USA

[2] Sleep Wake Disorders Ctr, Dept Neurol, Montpellier, France

[3] Natl Reference Network Narcolepsy, Montpellier, France

[4] Univ Montpellier, Inst Neurosci Montpellier INM, INSERM, Montpellier, France

来源：

JOURNAL OF SLEEP RESEARCH | 2024年 / 33卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P1223

引用

页数：1

共 50 条

[1] Impacts of treatment with TAK-861, an orexin receptor 2-selective agonist, on nocturnal sleep in people with narcolepsy type 1
Tracey, Brian
Gong, Yishu
Cai, Alice
Tierney, Patrick
Barateau, Lucie
Dauvilliers, Yves
Scammell, Thomas
Volfson, Dmitri
JOURNAL OF SLEEP RESEARCH, 2024, 33
[2] Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1
Dauvilliers, Y.
Mignot, E.
Villegas, R. del Rio
Du, Y.
Hanson, E.
Inoue, Y.
Kadali, H.
Koundourakis, E.
Meyer, S.
Rogers, R.
Scammell, T. E.
Sheikh, S. I.
Swick, T.
Szakacs, Z.
von Rosenstiel, P.
Wu, J.
Zeitz, H.
Murthy, N. V.
Plazzi, G.
von Hehn, C.
NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (04): : 309 - 321
[3] Impaired nocturnal blood pressure dipping in patients with type 2 diabetes mellitus
Yu-Sok Kim
Shyrin C. A. T. Davis
Wim J. Stok
Frans J. van Ittersum
Johannes J. van Lieshout
Hypertension Research, 2019, 42 : 59 - 66
[4] Impaired nocturnal blood pressure dipping in patients with type 2 diabetes mellitus
Kim, Yu-Sok
Davis, Shyrin C. A. T.
Stok, Wim J.
van Ittersum, Frans J.
van Lieshout, Johannes J.
HYPERTENSION RESEARCH, 2019, 42 (01) : 59 - 66
[5] Orexin 2 receptor-selective agonist danavorexton improves narcolepsy phenotype in a mouse model and in human patients
Evans, Rebecca
Kimura, Haruhide
Alexander, Robert
Davies, Ceri H.
Faessel, Helene
Hartman, Deborah S.
Ishikawa, Takashi
Ratti, Emiliangelo
Shimizu, Kohei
Suzuki, Motohisa
Tanaka, Shinichiro
Yukitake, Hiroshi
Dauvilliers, Yves
Mignot, Emmanuel
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (35)
[6] Danavorexton, a selective orexin 2 receptor agonist, provides a symptomatic improvement in a narcolepsy mouse model
Ishikawa, Takashi
Hara, Hiroe
Kawano, Ayumi
Kimura, Haruhide
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2022, 220
[7] Effects of Dulaglutide, A GLP-1 Agonist, on Ambulatory Diurnal and Nocturnal Blood Pressure in Patients with Type 2 Diabetes
Ferdinand, K. C.
Calhoun, D. A.
Lonn, E. M.
White, W. B.
Sager, P.
Jiang, H.
Threlkeld, R. J.
JOURNAL OF CLINICAL HYPERTENSION, 2013, 15
[8] TAK-861, a potent, orally available orexin receptor 2-selective agonist, produces wakefulness in monkeys and improves narcolepsy-like phenotypes in mouse models
Mitsukawa, Kayo
Terada, Michiko
Yamada, Ryuji
Monjo, Taku
Hiyoshi, Tetsuaki
Nakakariya, Masanori
Kajita, Yuichi
Ando, Tatsuya
Koike, Tatsuki
Kimura, Haruhide
SCIENTIFIC REPORTS, 2024, 14 (01):
[9] EVALUATION OF A NOVEL, ORALLY AVAILABLE OREXIN 2 RECEPTOR AGONIST, ON WAKEFULNESS AND CATAPLEXY IN A MOUSE MODEL OF TYPE 1 NARCOLEPSY
Brooks, J.
Sun, Y.
Kilduff, T.
Tan, L.
Raymer, B.
SLEEP MEDICINE, 2024, 115 : 216 - 216
[10] Effects of selective slow-wave sleep deprivation on nocturnal blood pressure dipping and daytime blood pressure regulation
Sayk, Friedhelm
Teckentrup, Christina
Becker, Christoph
Heutling, Dennis
Wellhoener, Peter
Lehnert, Hendrik
Dodt, Christoph
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2010, 298 (01) : R191 - R197

← 1 2 3 4 5 →